Physician profile
John Moore
NPI 1750577896
$68,262.21
in general payments reported to CMS, 2019-2025
7 companies · $40K in 2025
The $40K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $612 · 2020: $25K · 2021: $791 · 2022: $824 · 2023: $400 · 2024: $604 · 2025: $40K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $40K · Food and Beverage: $1,396 · Education: $25.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $40,000.00 |
| Food and Beverage | $1,396.40 |
| Education | $25.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $40,357.22 | 2024-2025 | Daxxify |
| Allergan, INC. | $26,143.96 | 2019-2022 | |
| Abbvie INC. | $866.86 | 2023-2025 | |
| Mentor Worldwide LLC | $515.86 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Memoryshape Breast Implant |
| Galderma Laboratories, L.P. | $340.27 | 2019-2025 | Dysport |
| Merz North America, INC. | $23.94 | 2021 | |
| Medtronic, INC. | $14.10 | 2025 | Ligasure |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.